Libertyville, IL, United States of America

Stevan Wakefield Djuric

This inventor holds 69 USPTO granted patents and 3 published patent applications, plus 9 CIPO patents and 9 EPO patents, primarily in Pharmaceutical Compositions (CPC class C07D). Top assignees: G.d. Searle & Company, Abbott Laboratories Corporation, Abbvie Inc.. Active years: 1986-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stevan Wakefield Djuric. Retrieved from https://idiyas.com/inventor/stevan-wakefield-djuric

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 69 (Patent Applications = 3)

% Patents Active = 78.3

CIPO Patents = 9 (Patent Applications = 10)

EPO Patents = 9 (Patent Applications = 8)

Average Co-Inventor Count = 4.1

ph-index = 11

Forward Citations = 462(Granted Patents)

Forward Citations (Not Self Cited) = 432(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Evanston, IL (US) (1986 - 1988)
Glenview, IL (US) (1988 - 1999)
Malvern, PA (US) (1996 - 2003)
Libertyville, PA (US) (2008)
Libertyville, IL (US) (2000 - 2018)
Lake Bluff, IL (US) (2019)

Company Filing History:

36 out of 1,323

G.d. Searle & Company

patents

13 out of 4,188

Abbott Laboratories Corporation

Abbvie Deutschland Gmbh and Co Kg

patents

5. 2 out of 39

Aventis Pharma Limited

Rhone-Poulenc Rorer Pharmaceuticals Inc.

patents

9. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1986-2019

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Kinase Inhibitors

5-HT Receptors

Dipeptidyl Peptidase-IV

Tricyclic Modulators

Oxazolidinone Agents

Leukotriene Antagonists

Antibacterial Compounds

Pyrrolidine Derivatives

Cyclobut-3-ene-1,2,-dione

Macrolide Compounds

Oxolide Antibacterials

69 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10266532 - Tricyclic modulators of TNF signaling (2019-04-23),

2. 9879033 - Modulators of 5-HT receptors and methods of use thereof (2018-01-30),

3. 9701679 - Modulators of 5-HT receptors and methods of use thereof (2017-07-11),

4. 9656955 - Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy (2017-05-23),

5. 9650334 - Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy (2017-05-16),

6. 9187483 - Modulators of 5-HT receptors and methods of use thereof (2015-11-17),

7. 9163007 - 5-substituted indazoles as kinase inhibitors (2015-10-20),

8. 8846951 - Modulators of 5-HT receptors and methods of use thereof (2014-09-30),

9. 8846663 - Modulators of 5-HT receptors and methods of use thereof (2014-09-30),

10. 8648069 - 5-substituted indazoles as kinase inhibitors (2014-02-11),

11. 8637546 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV) (2014-01-28),

12. 8546377 - Modulators of 5-HT receptors and methods of use thereof (2013-10-01),

13. 8518933 - Modulators of 5-HT receptors and methods of use thereof (2013-08-27),

14. 8119664 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) (2012-02-21),

15. 7956185 - Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases (2011-06-07),

Title: Stevan Wakefield Djuric - Pioneering Inventor from Libertyville

Introduction: Stevan Wakefield Djuric is a renowned inventor hailing from Libertyville, Illinois. His innovative spirit and dedication to creating groundbreaking solutions have earned him a significant place in the world of patents and inventions.

Latest Patents: Stevan Wakefield Djuric holds several patents in various fields, including technology, healthcare, and environmental sustainability. His recent patents focus on enhancing renewable energy sources and improving medical devices for better patient outcomes.

Career Highlights: With a career spanning over two decades, Stevan Wakefield Djuric has worked with leading research institutions and companies to bring his inventions to life. His commitment to pushing the boundaries of technology has led to numerous successful ventures and collaborations.

Collaborations: Throughout his career, Stevan Wakefield Djuric has collaborated with top universities, research institutions, and industry experts to further his innovative projects. His ability to work across disciplines and bring together diverse teams has been instrumental in his success as an inventor.

Conclusion: Stevan Wakefield Djuric's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor. His contributions to various fields continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.